Last week, Alphabet subsidiary Verily Life Sciences announced the end, at least for the foreseeable future, of its glucose-sensing contact lens collaboration with Novartis.
Verily CTO Brian Otis gave his thoughts in a blog post at the time, stressing the learnings the company got from the project. In a recent interview with MobiHealthNews, Novartis Global Head of Digital Development Jacob LaPorte...
Four years after announcing an ambitious — and often ridiculed — project to create a glucose-sensing contact lens along with Novartis subsidiary Alcon, Alphabet's Verily is throwing in the towel, the company announced in a blog post today. It will continue to work on two other medical contact lens projects, aimed at presbyopia and cataract surgery recovery.
"Our clinical work on the glucose-...
A team of South Korean researchers are the latest to tout a smart, glucose-sensing contact lens. In a research article published today in Science Advances, the team described soft lenses carrying a tiny LED light that automatically turns off in the event of high glucose levels, as well as their efforts to test the lens in vivo.
“The reliability and stability of soft contact lenses have been...
All of the diverse operations of Verily, the life sciences technology company that began its life as Google X Life Sciences, can be summed up with a simple sentence: We should be treating our bodies at least as well as we treat our cars.
At the Health 2.0 Fall Conference in Santa Clara this week, Verily Chief Technology Officer Brian Otis spoke with Health 2.0 cofounder and CEO Dr. Indu Subaya on...
Google and Novartis are working on two smart contact lenses, and news broke this week about both of them: A new patent application sheds light on how Google might power its glucose-sensing contact lens, just a week after partner Novartis told a Swiss newspaper it was on track for human trials in 2016 of an autofocus lens for presbyopia patients.
Patent applications don't always presage exactly...
Thiel Foundation has announced that Harry Gandhi, cofounder and CEO of digital health startup Medella Health will be a 2015 Thiel Fellow. Medella Health is developing glucose-sensing contact lenses.
This year's group of 20 Thiel Fellows were selected from 2,800 applicants. Fellows receive $100,000 and mentorship from the Foundation’s network of founders, investors, and scientists. They can...
